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contributed to its rapid dissemination. The study emphasises the importance of 1 clinical management in controlling the emergence of shared strains in CF. of European ancestry. The majority of mortality and morbidity in people with CF is 8 caused by chronic lung infection with Pseudomonas aeruginosa [1] . During chronic 9 infection P. aeruginosa adapts to the CF airway microenvironment, which promotes 10 multiple phenotypic and genotypic changes including enhanced resistance to 11 antibiotics, excessive exopolysaccharide production, auxotrophy, auxotrophic 12 metabolism, hypermutability and the loss of motility [2] [3] [4] [5] [6] [7] [8] . This evolution strategy has 13 been found to occur in parallel in different P. aeruginosa strains, suggesting that these 14 pathoadaptive modifications are important in the transition from an opportunistic 15 pathogen to a specialised pathogen of diseased human lungs [8] . 16
Person-to-person transmission of airway-adapted P. aeruginosa strains has 17 also been reported with the acquisition of some "shared strains" correlated with 18 adverse clinical outcomes [9] [10] [11] [12] [13] . AUST-02 is a prevalent shared strain in CF centres 19 7 option (-f a) and GTRGAMMA model of nucleotide substitution with a correction 1 for ascertainment bias (-m ASC_GTRGAMMA --asc-corr lewis) [26] . A 2 resolved phylogeny of the M3L7 genome sequences (generated in this study) was 3 constructed from a SNP matrix of 364 SNPs with the same settings as above. To determine the emergence of the M3L7 sub-type, Bayesian inference of the 10 evolutionary rates was conducted using BEAST 1.8.2 [30] . As input a set of 183 11
SNPs specific for M3L7 was used, excluding two hypermutator isolates (AUS937 and 12 AUS938) and the AUS970 outgroup. Regions of clustered SNPs, where at least three 13 SNPs were found within 10bp of each other, were also removed. Among the different 14 combinations of the molecular clock model (strict and constant relaxed lognormal), 15 substitution model (HKY, GTR) and population size change (coalescent constant and 16 exponential growth) models, the preferred combination of parameters selected based 17 on stepping stone sampling was strict molecular clock, HKY substitution model with 18 
Results and Discussion

9
Isolates selected for WGS in this study 10 One to three P. aeruginosa isolates were prospectively collected from single sputum 11 specimens obtained annually for culture as part of the Australian Clonal P.aeruginosa 12 in Cystic Fibrosis (ACPinCF) study [10] and a systematic surveillance study was 13 subsequently conducted to assess the prevalence of M3L7 between 2007 and 2011 14 [16] . M3L7 was identified in 28/509 (5.5%) P. aeruginosa isolates from 13/170 15 (7.6%) patients in 2007-2009 and in 21/519 (4.0%) P. aeruginosa isolates from 16 11/173 (6.4%) patients in 2011 [16] . Twenty-five of these isolates were selected from 17 all patients (patients 24 to 42; Additional File 1: Table S1 ) infected with M3L7 for 18 WGS in this study. 
M3L7 is a distinct sub-lineage of the AUST-02 shared strain 16
On the basis of the whole-genome core phylogeny, the 63 AUST-02 isolates form two 17 major discrete lineages (clades), M2 (n=34) and M3 (n=29), consistent with their 18 possession of mexZ-2 (codon substitution, A38T) or mexZ-3 (codon substitution, 19 T12N) alleles, respectively ( Figure 1 and Additional File 2: Figure S1 ). The M3L7 20 isolates (n=26; including 25 isolates sequenced here and a previously sequenced 21 AUST-02 genome, AUS22) form a monophyletic sub-lineage of AUST-02 within the 22 M3 clade that has diverged from all other AUST-02 isolates sequenced to date ( Figure  23 1). Three isolates (AUS853; AUS854; AUS970) within the M3 clade form deep-24 branching relationships at the base of the lineage and do not harbour the lasR-7 allele 1 (L7: 1 bp deletion, 438delG) that defines the M3L7 sub-type. Of the available AUST-2 02 sequences, isolate AUS970 (sequenced in this study) represented the AUST-02 3 genome that was most closely related to the M3L7 sub-lineage. In addition to the 4 mexZ-3 allele (M3), AUS970 carried a wild-type lasR-1 (L1) allele (therefore named 5 M3L1). Prince Charles Hospital (Additional File 3: Figure S2 ). This situation, combined with 17 limited capacity to segregate all patients, particularly when admitted to an inpatient 18 ward, may have contributed to shared-strain infections. Taken together, these results 19 support a single founder scenario in which a carrier of the M3L7 sub-type acted as a 20 donor within a CF centre with subsequent rapid dissemination in the resident CF 21 population. Notably, both sub-lineages of AUST-02 are prevalent in Queensland, 22
suggesting that their MCRA originated in this state; however, we cannot rule out 23 11 independent introductions of M3L7 and M2 founders into the local CF population 1 from outside the same geographical region (state). 2
Resolving the within-patient relationships of M3L7 provides evidence for both 3 continuous infection and person-to-person transmission 4
To investigate genomic evidence for continuous infection within patients and person-5 to-person transmission, we examined the pattern of SNP differences between isolates 6 in more detail. As described previously, the dataset included six pairs of M3L7 7 isolates (Additional File 2: Figure S1 After removal of the AUS937 and AUS938 isolates from the analysis, the 19 phylogeny of the M3L7 sub-lineage could be resolved further: a maximum of 47 core 20
SNPs separated the most divergent (AUS941 and AUS947) isolates (Additional File 21 4: Figure S3 and Additional File 5: Figure S4 ). The closest sequential within-patient 22
isolates (AUS956 and AUS957 from patient 41) differed by only two core SNPs 23 demonstrating a remarkably high degree of genome stability over a 4-year period 24 (Additional File 4: Figure S3 ). Within-patient isolates from patients 41 and 28 also 1 grouped together with high bootstrap support on the phylogeny, which is consistent 2 with continuous M3L7 infection across the two sampling time-points. Our analyses 3 also revealed that a very close relationship existed between the early and late isolates 4 from patients 30 and 31, which could also be due to continuous infection of the same 5 strain (Additional File 4: Figure S3 ). 6
In contrast, based on the Maximum-Likelihood phylogeny, the second isolate 7 (2011) cultured from patient 39 was grouped together with isolates from other 8 patients (patient 36; patient 37; patient 40) instead of only the earlier 2007 isolate 9 (Additional File 4: Figure S3 ). This indicates the possibility of multiple M3L7 cross-10 infection events as has been suggested for other shared strains [40] , which may occur 11 via the airborne route or during socialisation between patients [41, 42] . Pairwise SNP 12
comparisons between M3L7 isolates also shows a possible transmission pathway with 13 isolates AUS946 and AUS944 from patient 39 and patient 30, respectively, being the 14 most likely source of cross-infections (Additional File 5: Figure S4 ). 15 AUS22 (an M3L7 isolate sequenced as part of a different study) and AUS943 16 were both isolated from patient 32 just six days apart. However, these two isolates 17
were more closely related to isolates from other patients than to each other, which is 18 also suggestive of direct or indirect cross-infection between those patients (Additional 19 File 2: Figure S1 ). This finding highlights that short-term within-patient diversity of 20 shared strains during chronic infection (e.g. [17] ) needs to be considered in light of 21 the P. aeruginosa lung diversity of the local CF population as a whole. Clonal lineages are expected to accumulate mutations that enable adaptation of the 6 bacterium to a specific environmental niche of a human host [8] . A total of 44 shared 7
SNPs and nine shared indels were acquired after divergence of the M3L7 sub-lineage 8 from all other AUST-02 isolates of the M2 and M3 clades. Thirty-five SNPs were 9 non-synonymous (80%), resulting in a change of the amino acid sequence including 10 two premature stop codons (Additional File 6. Table S2 ). Four indels produced in-11 frame mutations, whilst five indels caused a shift in the reading frame (Additional 12
File 6: Table S2 ). were annotated with at least two functional categories and nine genes were part of 17 regulatory networks (Figure 3) [56] [57] [58] [59] ). The mutations found in genes correlated with antibiotic 2 resistance were also identified in M3L7 isolates collected in 2014 [17] and might help 3 explain the increased resistance described previously in the sub-type compared to 4 other strains [16] . Altogether this analysis suggests that the M3L7 sub-lineage is 5 characterised by mutations in genes that might have aided adaptation to the CF 6 airways prior to dissemination in the CF population [4, 8, 39, 60] . 7 8
Genomic variation due to large deletions 9
The draft genomes that comprise the M3L7 sub-lineage ranged in size from 6.15 to 10 6.25 Mbp, whereas the M3L1 isolate (AUS970) genome was substantially smaller 11 (6.05 Mbp). All genomes within the M3 clade had an average GC content of 66.5%. 12
Genome reduction is a typical evolutionary process that occurs during adaptation 13 within the CF lungs [61]; therefore, large genomic variations (>10 kb) were compared 14 between the AUST-02 isolates. 15
Major differences in genome size were not due to horizontal gene transfer but 16 attributed to several deletion events, summarised in Table 1 . For example, one M3L7 17 isolate (AUS947) lost a large 93 Kbp region encoding a number of virulence genes 18
including exoY (a T3SS secreted toxin), a three-part hydrogen cyanide biosynthesis 19 operon, hcnABC and part of the cupA1-A5 chaperone usher fimbrae operon (Table 1) . 20
Deletions of varying sizes encompassing exoY and hcnABC (of the same region) were 21 also missing in three other isolates within the M3 clade (AUS853; AUS854; AUS970) 22
suggesting that there was a selective pressure to lose the functionality of genes 23 encoded at this position. 24 15 A 40 Kbp putative prophage was present in five AUST-02 isolates from Perth 1 (AUS15; AUS874; AUS17; AUS876; AUS877) and one isolate from Brisbane 2 (AUS24) of the M2 clade. This prophage is present in nearly all M3L7 genomes 3 (absent in AUS958) and a previous study also observed the presence of the prophage 4 in 9/11 M3L7 isolates collected in 2014 [17] . Therefore, it is most likely that this 5 prophage was present in the last common ancestor of the M3L7 sub-lineage and was 6 vertically inherited. The prophage is inserted immediately adjacent to the mutS gene 7 and a search of the putative prophage sequence using the PhaST webtool predicts a 8 complete prophage that is only 9% identical to the P. aeruginosa F10 phage [35] . The 9 prophage is flanked by an 18 bp att sequence (TCTCTCAGCACACGCC) that 10 delineates the deletion in AUS958. 11 Table 1 . Comparison of deletion events larger than 10 Kb in the AUST-02 genomes. 1
Size (Kbp) PAO1 locus tags Features Genome Gene
Function
T3SS secreted toxin Hydrogen cyanide biosynthesis operon Chaperone usher fimbrae operon
• All other AUST02 isolates
Encodes halovibrin Pathogenesis related factor TonB-dependent receptor
• All other AUST-02 isolates *AUS15; AUS874; AUS17; AUS876; AUS877 (M2 clade)
In conclusion, the persistence of the AUST-02 shared strain in the CF 1 population in Australia has led to the emergence of a monophyletic sub-lineage 2 (M3L7) that is distinct from the M2 sub-lineage of AUST-02. Our WGS analysis 3 demonstrated that M3L7 strains are characterised by mutations in genes that are likely 4 to affect antibiotic resistance and virulence phenotypes. The rapid dissemination of 5 this clinically important sub-type is most likely due to a combination of adaptation to 6 the CF airway microenvironment and transmission between people attending the same 7 CF centre. This work highlights the importance of clinical management in the 8 emergence of shared strains amongst people with CF and provides a framework for 9 future efforts in real-time genomic surveillance to monitor the transmission and 10 pathogenicity of AUST-02 amongst the Australian CF population and to detect newly 11 emergent shared strains. Australia and all participants provided written, informed consent. 18
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